Cite
MLA Citation
Khanh T. Do et al.. “First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors.” Oncologist, vol. 26, 2021, pp. 925–e1918. http://access.bl.uk/ark:/81055/vdc_100145640011.0x000031